Glix 80mg Tablet contains Gliclazide, a sulfonylurea class oral hypoglycemic agent used in the management of type 2 diabetes mellitus. It functions by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with non-insulin-dependent diabetes. Glix 80mg is indicated as an adjunct to diet and exercise to achieve better blood glucose regulation when these measures alone are insufficient. The medication is typically administered once daily, preferably with breakfast, to optimize efficacy and minimize the risk of hypoglycemia. Gliclazide has a relatively selective action on pancreatic receptors, which may reduce the incidence of hypoglycemic episodes compared to other sulfonylureas. Patients should be monitored regularly for blood glucose levels, renal and hepatic function, and signs of hypoglycemia. Caution is advised in patients with severe renal or hepatic impairment, and it is contraindicated in type 1 diabetes mellitus, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Common adverse effects include hypoglycemia, gastrointestinal disturbances, and allergic reactions. Glix 80mg should be used under medical supervision with appropriate lifestyle modifications to achieve optimal therapeutic outcomes in type 2 diabetes management.